Hemodynamic responses to aortic depressor nerve stimulation in conscious L-NAME-induced hypertensive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 2, 2011, Pages

  Durand, Marina De Toledo ^a   Castania, Jaci A ^a   Fazan Jr , Rubens ^a   Salgado, Maria Cristina Oliveira ^a   Salgado, Helio Cesar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autonomic nervous system; Baroreceptors; Electric stimulation; Nitric oxide; Nitro L arginine methyl ester

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN II; ATENOLOL; BETA ADRENERGIC RECEPTOR; METHYLATROPINE; MUSCARINIC M2 RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRAZOSIN;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA NERVE; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CHOLINERGIC ACTIVITY; DEPRESSOR RESPONSE; HEART HEMODYNAMICS; HYPERTENSION; MALE; NERVE STIMULATION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; VASODILATATION;

ANGIOTENSIN II; ANIMALS; AORTA; ATENOLOL; ATROPINE DERIVATIVES; BAROREFLEX; BLOOD PRESSURE; ELECTRIC STIMULATION; HEART RATE; HEMODYNAMICS; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; PARASYMPATHOLYTICS; PRAZOSIN; RATS; RATS, WISTAR;

EID: 79551545012     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00463.2010     Document Type: Article

References (52)

1. Banting JD, Wiseman SL, Adams MA. Hypertension without cardiac hypertrophy does not induce a cardiac baroreflex deficit. J Hypertens 14: 1209-1214, 1995.
2. Coleman TG. Arterial baroreflex control of heart rate in conscious rat. Am J Physiol Heart Circ Physiol 238: H515-H520, 1980.
3. De Paula PM, Castania JA, Bonagamba LGH, Salgado HC, Machado BH. Hemodynamic responses to electrical stimulation of the aortic depressor nerve in awake rats. Am J Physiol Regul Integr Comp Physiol 277: R31-R38, 1999.
4. Dias AC, Vitela M, Colombari E, Mifflin SW. Nitric oxide modulation of glutamatergic, baroreflex and cardiopulmonary transmission in the nucleus of the solitary tract. Am J Physiol Heart Circ Physiol 288: H256-H262, 2005.
5. Dos Santos FM, Martins Dias DP, da Silva CA, Fazan R Jr, Salgado HC. Sympathetic activity is not increased in L-NAME hypertensive rats. Am J Physiol Regul Integr Comp Physiol 298: R89-R95, 2010.
6. Doumas M, Guo D, Papademetriou V. Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions. Expert Opin Ther Targets 13: 413-425, 2009.
7. Faber W, Brody MJ. Reflex hemodynamic response to superior laryngeal nerve stimulation in the rat. J Auton Nerv Syst 9: 607-622, 1983.
8. Gao XY, Huang XL, Wang HJ, Zhou LM, Xu Y, Wang W, Zhu GQ. Depressor effect of closed-loop chip system in spontaneously hypertensive rats. Auton Neurosci 137: 84-91, 2007.
9. Gao XY, Wang HJ, Zhang Y, Lu ZH, Wang W, Zhu GQ. Resetting blood pressure by a closed-loop implanted chip system in normotensive rats. Life Sci 78: 1129-1134, 2006.
10. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57: 683-706, 1995.
11. Glick G, Braunwald E. Relative roles of the sympathetic and parasympathetic nervous systems in the reflex control of heart rate. Circ Res 16: 363-375, 1965.
12. Head GA, McCarty R. Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats. J Auton Nerv Syst 21: 203-213, 1987.
13. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55: 619-626, 2010.
14. Höhler B, Mayer B, Kummer W. Nitric oxide synthase in the rat carotid body and carotid sinus. Cell Tissue Res 276: 559-564, 1994.
15. Iliescu R, Lohmeier TE. Mechanisms of blood pressure reduction by prolonged activation of the baroreflex. Conf Proc IEEE Eng Med Biol Soc 2009: 2040-2042, 2009.
16. Iliescu R, Lohmeier TE. Lowering of blood pressure during chronic suppression of central sympathetic outflow: insight from computer simulations. Clin Exp Pharmacol Physiol 37: e24-e33, 2010.
17. Kougias P, Weakley SM, Yao Q, Lin PH, Chen C. Arterial baroreceptors in the management of systemic hypertension. Med Sci Monit 16: 1-8, 2010.
18. Li Z, Chapleau MW, Bates JN, Bielefeldt K, Lee HC, Abboud FM. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 20: 1039-1049, 1998.
19. Lin LH, Talman WT. Vesicular glutamate transporters and neuronal nitric oxide synthase colocalize in aortic depressor afferent neurons. J Chem Neuroanat 32: 54-64, 2006.
20. Liu HK, Guild SJ, Ringwood JV, Barrett CJ, Leonard BL, Nguang SK, Navakatikyan MA, Malpas SC. Dynamic baroreflex control of blood pressure: influence of the heart vs. peripheral resistance. Am J Physiol Regul Integr Comp Physiol 283: R533-R542, 2002.
21. Liu J, Murakami H, Zucker IH. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 270: R1361-R1370, 1996.
22. Lohmeier TE, Dwyer TM, Hildebrandt DA, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension 46: 1194-1200, 2005.
23. Lohmeier TE, Dwyer TM, Irwin ED, Rossing MA, Kieval RS. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 49: 1307-1314, 2007.
24. Lohmeier TE, Hildebrandt DA, Dwyer TM, Iliescu R, Irwin ED, Cates AW, Rossing MA. Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade. Hypertension 53: 833-838, 2009.
25. Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 43: 306-311, 2004.
26. Machado BH, Bonagamba LG, Castania JA, Menani JV. Aortic baroreceptors play a predominant role in the regulation of hindlimb vascular resistance in rats. Am J Physiol Regul Integr Comp Physiol 267: R476-R480, 1994.
27. Matsuda T, Bates JN, Lewis SJ, Abboud FM, Chapleau MW. Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. Circ Res 76: 426-433, 1995.
28. Mayorov DN. Selective sensitization by nitric oxide of sympathetic baroreflex in rostral ventrolateral medulla of conscious rabbits. Hypertension 45: 901-906, 2005.
29. Meyrelles SS, Sharma RV, Mao HZ, Abboud FM, Chapleau MW. Modulation of barorreceptor activity by gene transfer of nitric oxide synthase to carotid sinus adventitia. Am J Physiol Regul Integr Comp Physiol 284: R1190-R1198, 2003.
30. Navarro-Cid J, Maeso R, Rodrigo E, Muñoz-García R, Ruilope LM, Lahera V, Cachofeiro V. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens 9: 1077-1083, 1996.
31. Pechánová O, Bernátová I, Babál P, Martínez MC, Kyselá S, Stvrtina S, Andriantsitohaina R. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 22: 1551-1559, 2004.
32. Possas OS, Johnson AK, Lewis SJ. Role of nitrosyl factors in the hindlimb vasodilation elicited by baroreceptor afferent nerve stimulation. Am J Physiol Regul Integr Comp Physiol 290: R741-R748, 2006.
33. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86: 3375-3378, 1989.
34. Ribeiro MO, Antunes E, Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
35. Salgado HC, Barale AR, Castania JA, Machado BH, Chapleau MW, Fazan R Jr. Baroreflex responses to electrical stimulation of aortic depressor nerve in conscious SHR. Am J Physiol Heart Circ Physiol 292: H593-H600, 2007.
36. Salgado MCO, Justo SV, Joaquim LF, Fazan R, Salgado HC. Role of nitric oxide and prostanoids in attenuation of rapid baroreceptor resetting. Am J Physiol Heart Circ Physiol 290: H1059-H1063, 2006.
37. Schall R. Estimation in generalized linear models with random effects. Biometrika 78: 719-727, 1991.
38. Scrogin KE, Hatton DC, Chi Y, Luft FC. Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol Regul Integr Comp Physiol 274: R367-R374, 1998.
39. Sears CE, Choate JK, Paterson DJ. Effect of nitric oxide synthase inhibition on the sympatho-vagal control of heart rate. J Auton Nerv Syst 73: 63-73, 1998.
40. Souza HCD, Ballejo G, Salgado MCO, Silva VJD, Salgado HC. Cardiac sympathetic overactivity and decreased baroreflex sensitivity in L-NAME hypertensive rats. Am J Physiol Heart Circ Physiol 280: H844-H850, 2001.
41. Stornetta RL, Guyenet PG, McCarty RC. Autonomic nervous system control of heart rate during baroreceptor activation in conscious and anesthetized rats. J Auton Nerv Syst 20: 121-127, 1987.
42. Talman WT, Dragon DN. Transmission of arterial baroreflex signals depends on neuronal nitric oxide synthase. Hypertension 43: 820-824, 2004.
43. Tordoir JHMS, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B, Herold U, Irwin E, Kroon AA, de Leeuw P, Peters TK, Kieval R, Cody R. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 33: 414-421, 2007.
44. Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, Hurn PD. Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain. Stroke 26: 864-869, 1995.
45. Tseng C, Liu H, Lin H, Ger L, Tung C, Yen M. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 27: 36-42, 1996.
46. Wang DS, Xie HH, Shen FM, Cai GJ, Su DF. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin Exp Pharmacol Physiol 31: 212-218, 2005.
47. Whalen EJ, Bates JN, Johnson AK, Lewis SJ. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis. Br J Pharmacol 147: 755-764, 2006.
48. Whalen EJ, Johnson AK, Lewis SJ. Effects of nitric oxide synthase inhibition on sympathetically-mediated tachycardia. Eur J Pharmacol 365: 217-223, 1999.
49. 2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y. Exp Physiol 94: 31-37, 2009.
50. Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, Schmidli J, Allemann Y, Delacrétaz E. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension 54: 530-536, 2009.
51. Zanchi A, Schha NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Effects of chronic NO synthase inhibition in rats on rennin-angiotensin and sympathetic nervous system. Am J Physiol Heart Circ Physiol 268: H2267-H2273, 1995.
52. Zhou LM, Zhu GQ, Wang HJ, Zhao CK, Xu Y, Gao XY. Antihypertensive effects of a closed-loop chip system in renovascular hypertensive rats. Med Sci Monit 14: 153-158, 2008.